Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population

BMC Microbiology

Volumn 6, Issue , 2006, Pages

  Yoonim, Nonglak ^a   Olive, Colleen ^b   Pruksachatkunakorn, Chulabhorn ^a   Pruksakorn, Sumalee ^a  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTISERUM; M PROTEIN;

ARTICLE; BACTERIAL GENE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATION; CARBOXY TERMINAL SEQUENCE; EMM GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SEQUENCE; STREPTOCOCCUS GROUP A; THAILAND;

AMINO ACID SEQUENCE; ANTIBODIES; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; CONSERVED SEQUENCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; POLYMERASE CHAIN REACTION; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS PYOGENES; TERMINAL REPEAT SEQUENCES; THAILAND;

EID: 33748283932     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-6-71     Document Type: Article

References (33)

1. Cunningham MW: Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 2000, 13:470-511.
2. Brandt ER, Hayman WA, Currie B, Carapetis J, Wood Y, Jackson DC, Cooper J, Melrose WD, Saul AJ, Good MF: Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunology 1996, 89:331-337.
3. Brandt ER, Hayman WA, Currie B, Pruksakorn S, Good MF: Human antibodies to the conserved region of the M protein:Opsonisation of heterologous strains of group A streptococci. Vaccine 1997, 15:1805-1812.
4. Brandt ER, Sriprakash KS, Hobb RI, Hayman WA, Zeng W, Batzloff MR, Jackson DC, Good MF: New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population. Nat Med 2000, 6:455-459.
5. Brandt ER, Teh T, Relf WA, Hobb RI, Good MF: Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci. Infect Immun 2000, 68:6587-6594.
6. Streptococcus emm types [http://www.cdc.gov/ncidod/biotech/strep/ emmtypes.htm]
7. Moses AE, Hidalgo-Grass C, Dan-Goor M, Jaffe J, Shetzigovsky I, Ravins M, Korenman Z, Cohen-Poradosu R, Nir-Paz R: emm typing of M nontypeable invasive group A streptococcal isolates in Israel. J Clin Microbiol 2003, 41:4655-4659.
8. Pruksakorn S, Sittisombut N, Phornphutkul C, Pruksachatkunakorn C, Good MF, Brandt E: Epidemiological analysis of non-M-typeable group A Streptococcus isolates from a Thai population in northern Thailand. J Clin Microbiol 2000, 38:1250-1254.
9. Tran PO, Johnson DR, Kaplan EL: The presence of M protein in nontypeable group A streptococcal upper respiratory tract isolates from Southeast Asia. J Infect Dis 1994, 169:658-661.
10. Hu MC, Walls MA, Stroop SD, Reddish MA, Beall B, Dale JB: Immunogenicity of a 26-valent group A streptococcal vaccine. Infect Immun 2002, 70:2171-2177.
11. Kotloff KL, Corretti M, Palmer K, Campbell JD, Reddish MA, Hu MC, Wasserman SS, Dale JB: Safety and immunogenicity of a recombinant multivalent group a streptococcal vaccine in healthy adults: phase 1 trial. JAMA 2004, 292:709-715.
12. Hall MA, Stroop SD, Hu MC, Walls MA, Reddish MA, Burt DS, Lowell GH, Dale JB: Intranasal immunization with multivalent group A streptococcal vaccines protects mice against intranasal challenge infections. Infect Immun 2004, 72:2507-2512.
13. Dale JB: Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments. Vaccine 1999, 17:193-200.
14. Mannam P, Jones KF, Geller BL: Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes. Infect Immun 2004, 72:3444-3450.
15. Batzloff MR, Yan H, Davies MR, Hartas J, Lowell GH, White G, Burt DS, Leanderson T, Good MF: Toward the development of an antidisease, transmission-blocking intranasal vaccine for group a streptococcus. J Infect Dis 2005, 192:1450-1455.
16. Pruksakorn S, Galbraith A, Houghten RA, Good MF: Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies. J Immunol 1992, 149:2729-2735.
17. Bessen D, Fischetti VA: Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol 1990, 145:1251-1256.
18. Pruksakorn S, Currie B, Brandt E, Martin D, Galbraith A, Phornphutkul C, Hunsakunachai S, Manmontri A, Good MF: Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Lancet 1994, 344:639-642.
19. Pruksakorn S, Currie B, Brandt E, Phornphutkul C, Hunsakunachai S, Manmontri A, Robinson JH, Kehoe MA, Galbraith A, Good MF: Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci. Int Immunol 1994, 6:1235-1244.
20. Hayman WA, Brandt ER, Relf WA, Cooper J, Saul A, Good MF: Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. Int Immunol 1997, 9:1723-1733.
21. Vohra H, Dey N, Gupta S, Sharma AK, Kumar R, McMillan D, Good MF: M protein conserved region antibodies opsonise multiple strains of Streptococcus pyogenes with sequence variations in C-repeats. Res Microbiol 2005, 156:575-582.
22. Sandin C, Carlsson F, Lindahl G: Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes. Mol Microbiol 2006, 59:20-30.
23. McArthur JD, Walker MJ: Domains of group A streptococcal M protein that confer resistance to phagocytosis, opsonization and protection: implications for vaccine development. Mol Microbiol 2006, 59:1-4.
24. Olive C, Hsien K, Horvath A, Clair T, Yarwood P, Toth I, Good MF: Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides. Vaccine 2005, 23:2298-2303.
25. Olive C, Batzloff MR, Horvath A, Wong A, Clair T, Yarwood P, Toth I, Good MF: A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies. Infect Immun 2002, 70:2734-2738.
26. Batzloff MR, Hayman WA, Davies MR, Zeng M, Pruksakorn S, Brandt ER, Good MF: Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection. J Infect Dis 2003, 187:1598-1608.
27. Jackson DC, O'Brien-Simpson N, Ede NJ, Brown AE: Free radical induced polymerization of synthetic peptides into polymeric immunogens. Vaccine 1997, 15:1697-1705.
28. Toth I, Danton M, Flinn N, Gibbons WA: A combined adjuvant and carrier system for enhancing synthetic peptides immunogenicity utilising lipidic amino acids. Tetrahedron Lett 1993, 34:3925-3928.
29. Olive C, Ho M, Dyer J, Lincoln D, Barozzi N, Toth I, Good MF: Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. J Infect Dis 2006, 193:1666-1676.
30. Olive C, Batzloff M, Horvath A, Clair T, Yarwood P, Toth I, Good MF: Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens. Infect Immun 2003, 71:2373-2383.
31. Yoonim N, Olive C, Pruksachatkunakorn C, Good MF, Pruksakorn S: M protein typing of Thai group A streptococcal isolates by PCR-Restriction fragment length polymorphism analysis. BMC Microbiol 2005, 5:63.
32. Manjula BN, Khandke KM, Fairwell T, Relf WA, Sriprakash KS: Heptad motifs within the distal subdomain of the coiled-coil rod region of M protein from rheumatic fever and nephritis associated serotypes of group A streptococci are distinct from each other: nucleotide sequence of the M57 gene and relation of the deduced amino acid sequence to other M proteins. J Protein Chem 1991, 10:369-384.
33. Podbielski A, Melzer B, Lutticken R: Application of the polymerase chain reaction to study the M protein(-like) gene family in beta-hemolytic streptococci. Med Microbiol Immunol (Berl) 1991, 180:213-227.